MediPharm Labs Completes First Shipment Of Cannabis Topicals

(RTTNews) - MediPharm Labs Corp., a Canada-based provider of cannabis oil and concentrates, said it has completed its first shipment of bottled cannabis topicals under a contract manufacturing agreement.

In addition, the company is accelerating its research and development program to bolster its presence in the growing Canadian and future international medical as well as adult-use topicals markets.

Leveraging its 25,000 sq. ft. licensed space, MediPharm Labs completed its first shipment of topicals from its GMP-certified Barrie facility this week, including the filling and packaging on behalf of its customer. The topicals, shipped on Tuesday, will be distributed directly by the consumer to final medical or adult-use purchasers.

MediPharm Labs noted that cannabis-infused topicals are already legal in its home country of Canada, providing the company an excellent near-term market opportunity.

"Following Cannabis 2.0 legalization in Canada, it's clear there is demand for cannabis topicals. We also expect worldwide demand for topicals could increase as new cannabis markets start to come online and legalize concentrate based products," said Pat McCutcheon, Chief Executive Officer of MediPharm Labs.
See also:
Leave a comment
  • Latest
  • Read
  • Commented
Calendar Content
«    Май 2020    »